课题基金 / 基金详情

Characterization Of Wilms Tumor Suppressor Gene Product

Characterization Of Wilms Tumor Suppressor Gene Product
维尔姆斯肿瘤抑制基因产物的表征
批准号:
7337558
负责人:
Sean B. Lee
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Sean B. Lee的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Wilms tumor suppressor gene WT1, which is mutated in 10-15% of Wilms tumor -- a pediatric kidney cancer -- encodes a transcription factor with C2H2 zinc finger DNA binding domain. WT1 is proposed to regulate transcription of genes that are critical for the initiation and differentiation of kidney, gonad, spleen, and adrenal gland since wt1-null mouse embryos lack all of these organs. In addition to Wilms tumor, other human syndromes and diseases are also caused by mutations in the WT1 gene such as Danys-Drash and Frasier syndromes. Using microarray expression profiling, we have identified a number of WT1 target genes that appears to be important for kidney development. The target genes were independently verified using quantitative RT-PCR, chromatin-immunoprecipitation, promoter-reporter assay and expression in WT1-positive cells in the develping kidneys. To examine the physiological role of these targets during kidney development, we used in vitro kidney organ culture assay to determine their effects on kidney differentiation. Identification of the target genes and defining their role during development will provide further insights to the development of Wilms tumor and organogenesis in general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Integrative Approach to Identify Vulnerabilities in Pediatric Cancer DSRCT
  • 批准号:
    10553217
  • 项目类别:
  • 资助金额:
    $30.37万
  • 财政年份:
    2019
  • 负责人:
    Sean B. Lee
  • 依托单位:
An Integrative Approach to Identify Vulnerabilities in Pediatric Cancer DSRCT
  • 批准号:
    10360445
  • 项目类别:
  • 资助金额:
    $30.37万
  • 财政年份:
    2019
  • 负责人:
    Sean B. Lee
  • 依托单位:
An Integrative Approach to Identify Vulnerabilities in Pediatric Cancer DSRCT
  • 批准号:
    10092975
  • 项目类别:
  • 资助金额:
    $19.61万
  • 财政年份:
    2019
  • 负责人:
    Sean B. Lee
  • 依托单位:
Desmoplastic Small Round Cell Tumor/Ewings Sarcoma Model
国内基金
海外基金
引起Wilms肿瘤的miRNA加工复合体突变的分子机制
  • 批准号:
    32371355
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    Tuan Anh Nguyen
  • 依托单位:
Six1在Wilms肿瘤发病中的作用及分子机制: 巴马小型猪模型的构建
  • 批准号:
    31971379
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2019
  • 负责人:
    李荣凤
  • 依托单位:
WT1在DNA损伤应答中的功能及诱导Wilms肿瘤的分子机制
  • 批准号:
    81874160
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    俞晓春
  • 依托单位:
p53基因突变促进Wilms 肿瘤发展转移的小鼠动物模型研究
  • 批准号:
    81472715
  • 项目类别:
    面上项目
  • 资助金额:
    75.0万元
  • 批准年份:
    2014
  • 负责人:
    胡强华
  • 依托单位: